Volume 95, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



We developed and validated a new analytical method for the simultaneous quantification of artemether and lumefantrine in fixed-dose tablets and powders for reconstitution into pediatric suspensions (PSs). The method showed linearity ( > 0.9947), precision (coefficient of variation < 2%), accuracy (deviation of mean from actual concentrations < 4%), and specificity (peak purities > 99%). The validated method was used to analyze 24 batches of fixed-dose tablets and PSs of artemether and lumefantrine. Of the samples, 23 were obtained using convenience sampling of commonly available brands within Accra in Ghana and one was obtained from Aarhus University Hospital. In all, 83.3% (confidence interval: 80–120%) passed for both artemether and lumefantrine contents, 16.7% failed by the U.S. Pharmacopoeia standards, 8.3% failed for one content, and 8.3% failed for both contents. All four products (16.7%) that failed were PSs, and two (8.3%) showed higher levels of artemether than prescribed (222% and 756%).


Article metrics loading...

Loading full text...

Full text loading...



  1. WHO, 2012. Factsheet on the World Malaria Report 2012. Available at: http://www.who.int/malaria/media/world_malaria_report_2012_facts/en/. Accessed November 15, 2013.
  2. WHO, 2012. World Malaria Report 2012. Available at: http://www.who.int/malaria/publications/world_malaria_report_2012/en/index.html. Accessed November 15, 2013.
  3. Cesar ID, Nogueira FHA, Pianetti GA, , 2008. Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection. J Pharm Biomed Anal 48: 951954.[Crossref]
  4. WHO, 2000. WHO Expert Committee on Malaria: Twentieth Report. WHO Technical Report Series 892. Available at: http://apps.who.int/iris/bitstream/10665/42247/1/WHO_TRS_892.pdf. Accessed November 15, 2013.
  5. WHO, 2006. Counterfeit Medicines: The Silent Epidemic. Available at: http://www.who.int/mediacentre/news/releases/2006/pr09/en/. Accessed November 15, 2013.
  6. Nayyar GML, Breman JG, Newton PN, Herrington J, , 2012. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12: 488496.[Crossref]
  7. WHO, 2001. Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation, April 4–5, 2001. Available at: http://apps.who.int/iris/bitstream/10665/66952/1/WHO_CDS_RBM_2001.35.pdf. Accessed November 15, 2013.
  8. Green MD, Mount DL, Wirtz RA, , 2001. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method. Trop Med Int Health 6: 980982.[Crossref]
  9. Atemnkeng MA, De Cock K, Plaizier-Vercammen J, , 2007. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo. Trop Med Int Health 12: 6874.
  10. Arun R, Smith AA, , 2011. Simultaneous HPLC-UV method for the estimation of artemether and lumefantrine in tablet dosage form. Int J Pharm Biomed Res 2: 201205.
  11. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ, , 2000. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 44: 697704.[Crossref]
  12. Hodel EM, Zanolari B, Mercier T, Biollaz J, Keiser J, Olliaro P, Genton B, Decosterd LA, , 2009. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 877: 867886.[Crossref]
  13. Cesar IC, de Aquino Ribeiro JA, de Souza Teixeira L, Bellorio KB, de Abreu FC, Moreira JM, Chellini PR, Pianetti GA, , 2011. Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study. J Pharm Biomed Anal 54: 114120.[Crossref]
  14. WHO, 2003. Substandard and Counterfeit Medicines. Geneva, Switzerland: World Health Organization.
  15. Newton PN, Green MD, Fernández FM, Day NP, White NJ, , 2006. Counterfeit anti-infective drugs. Lancet Infect Dis 6: 602613.[Crossref]
  16. Bate R, Coticelli P, Tren R, Attaran A, , 2008. Antimalarial drug quality in the most severely malarious parts of Africa: a six country study. PLoS One 3: e2132.[Crossref]
  17. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NP, Greenwood BM, Nosten F, White NJ, , 2006. Manslaughter by fake artesunate in Asia: will Africa be next? PLoS Med 3: e197.[Crossref]
  18. Ofori-Kwakye K, Asantewaa Y, Gaye O, , 2008. Quality of artesunate tablets sold in pharmacies in Kumasi, Ghana. Trop J Pharm Res 7: 11791184.[Crossref]
  19. Yamey G, Schäferhoff M, Montagu D, , 2012. Piloting the Affordable Medicines Facility-Malaria: What Will Success Look Like? Bulletin of the World Health Organization. Available at: http://www.who.int/bulletin/volumes/90/6/11-093849/en/. Accessed November 15, 2013.
  20. WHO, 2014. Malaria: High-Risk Groups. Available at: http://www.who.int/malaria/areas/high_risk_groups/en/. Accessed November 5, 2014.
  21. Moormann AM, , 2009. How might infant and paediatric immune responses influence malaria vaccine efficacy? Parasite Immunol 31: 547559.[Crossref]

Data & Media loading...

  • Received : 01 Dec 2015
  • Accepted : 15 Feb 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error